Andersen-Tawil syndrome classification: Difference between revisions
Line 16: | Line 16: | ||
OR | OR | ||
Andersen–Tawil syndrome may be classified according to genetic mutations into two groups: | |||
* [Group1] | * [Group1] |
Revision as of 17:04, 28 January 2020
Andersen-Tawil syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Andersen-Tawil syndrome classification On the Web |
American Roentgen Ray Society Images of Andersen-Tawil syndrome classification |
Risk calculators and risk factors for Andersen-Tawil syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Andersen–Tawil syndrome may be classified according to genetic mutations into two groups: Type 1 Andersen–Tawil syndrome and type 2 Andersen–Tawil syndrome
- Type 1, which accounts for about 60 percent of all cases of the disorder, is caused by mutations in the KCNJ2 gene. [1][2]
- The remaining 40 percent of cases are designated as type 2; the cause of the condition in these cases is unknown.
Classification
There is no established system for the classification of [disease name].
OR
Andersen–Tawil syndrome may be classified according to genetic mutations into two groups:
- [Group1]
- [Group2]
- [Group3]
- [Group4]
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
[Disease name] may be classified into several subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
References
- ↑ Tristani-Firouzi M, Jensen JL, Donaldson MR; et al. (2002). "Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)". J. Clin. Invest. 110 (3): 381–8. PMID 12163457.
- ↑ Pegan S, Arrabit C, Slesinger PA, Choe S (2006). "Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1". Biochemistry. 45 (28): 8599–606. doi:10.1021/bi060653d. PMID 16834334.